Low-dose intermittent urokinase therapy in chronic symptomatic end- stage arterial disease - Clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease

Clinical Hemorheology and Microcirculation

Volumn 17, Issue 1, 1997, Pages 59-66

  Leschke, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antithrombotic therapy; Coronary artery disease; Ischemia; Peripheral arterial occlusive disease

Indexed keywords

UROKINASE;

ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG USE; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; ISCHEMIA; THROMBOLYTIC THERAPY; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030790473     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. K. Alexander, V. Buhl, D. Holsten, H. Poliwoda and H.H. Wagner, Fibrinolytische Therapie des chronischen Arterienverschlusses, Med. Klin. 51 (1968), 2067-2070.
2. K. Alexander, Konservative Therapie der peripheren arteriellen Durchblutungsstörungen, Z. Kardiol. 82(Suppl. 5) (1993), 89-98.
3. A. Bini, J.J. Fenoglia, R. Mesa-Tejada, B. Kudryk and K.L. Kaplan, Identification and distribution of fibrinogen, fibrin and fibrin(ogen) degradation products in atherosclerosis: use of monoclonal antibody, Arteriosclerosis 9 (1989), 109-121.
4. H. Böhme and S. Heil, Klinische Erfahrungen mit der intermittierenden intraarteriellen Infusion von Urokinase im Stadium III und IV der peripheren arteriellen Verschlußkrankheit, in: Konservative Therapie arterieller Durchblutungsstörungen, G. Trübestein, ed., Thieme, 1986, pp. 442-445.
5. H. Böhme, Die konservative Therapie der chronischen peripheren arteriellen Verschlußkrankheit, Chir. Gastroenterol. 8(Suppl. 1) (1992), 76-80.